PRUCALOPRIDE MedTAS prucalopride (as succinate) 2 mg film-coated tablet blister pack

البلد: أستراليا

اللغة: الإنجليزية

المصدر: Department of Health (Therapeutic Goods Administration)

العنصر النشط:

prucalopride succinate, Quantity: 2.64 mg (Equivalent: prucalopride, Qty 2 mg)

متاح من:

MedTAS Pty Ltd

الشكل الصيدلاني:

Tablet, film coated

تركيب:

Excipient Ingredients: lactose monohydrate; microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate; titanium dioxide; hypromellose; triacetin; iron oxide yellow; iron oxide red; macrogol 3000; indigo carmine aluminium lake

طريقة التعاطي:

Oral

الوحدات في الحزمة:

28 film-coated tablets

نوع الوصفة الطبية :

(S4) Prescription Only Medicine

الخصائص العلاجية:

Prucalopride is indicated for the treatment of chronic functional constipation in adults in whom laxatives fail to provide adequate relief. ? Before Prucalopride is considered patients must have tried at least two different types of laxatives from different classes (at the highest tolerated recommended doses) for at least six months, but have not had adequate relief from constipation. ? If treatment with Prucalopride is not effective within four weeks, the benefit of continuing treatment should be reconsidered.

ملخص المنتج:

Visual Identification: Pink, round biconvex, film coated tablets debossed with P2 on one side and no debossing on the other side.; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

الوضع إذن:

Registered

تاريخ الترخيص:

2022-09-12